Latest news
Vera's TRUTAKNA Gets FDA Accelerated Approval for IgA Nephropathy - Stock TitanStock Titan · Mon, 10 Aug 2026 20:05:00 GMTCompass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights - Via RitzauVia Ritzau · Wed, 05 Aug 2026 10:30:00 GMTFirst half 2026 results approved - FincantieriFincantieri · Wed, 29 Jul 2026 10:35:57 GMT